A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis

Benjamin A Thomas1, James S Molton, Francesca Leek

  • 1aAgency for Science Technology and Research, National University of Singapore Clinical Imaging Research Centre bDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore cUniversity Medicine Cluster, National University Health System, Singapore dInstitute of Nuclear Medicine, University College London, London, UK.

Abstract

Insights

Positron emission tomography/magnetic resonance (PET/MR) imaging detects a comparable number of pulmonary tuberculosis (PTB) lesions as PET/computed tomography (CT). While standardized uptake values (SUVs) are lower with PET/MR, this difference is unlikely to impact research assessments of treatment response.

Area of Science:

  • Nuclear Medicine
  • Radiology
  • Infectious Disease Research

Background:

  • Positron emission tomography/computed tomography (PET/CT) is used to detect lesions in pulmonary tuberculosis (PTB).
  • Concerns regarding radiation dose in clinical research for curable diseases like PTB exist.
  • PET/MR imaging offers a potential alternative with reduced radiation exposure.

Purpose of the Study:

  • To determine the equivalence of PET/MR imaging compared to PET/CT for detecting PTB lesions.
  • To evaluate the quantitative differences in standardized uptake values (SUVs) between PET/MR and PET/CT in PTB patients.

Main Methods:

  • Ten patients with confirmed PTB underwent both PET/MR and PET/CT imaging after receiving fluorine-18-fluorodeoxyglucose.
  • Imaging sequences were performed in a crossover design (PET/MR then PET/CT, or vice versa).
  • Lesion detection rates and standardized uptake values (SUVs) were compared between modalities; CT Hounsfield units were correlated with MR-based attenuation correction.

Main Results:

  • A total of 108 PTB lesions were detected by PET/MR and 112 by PET/CT.
  • Mean and maximum SUVs were significantly lower on PET/MR compared to PET/CT.
  • Dixon-based attenuation correction in PET/MR underestimated the linear attenuation coefficient of PTB lesions.

Conclusions:

  • PET/MR demonstrates comparable visual performance to PET/CT in detecting PTB lesions.
  • Lower SUVs on PET/MR are attributed to attenuation correction methods but are unlikely to affect research assessments of treatment response.
  • PET/MR is a viable alternative to PET/CT for PTB research, offering reduced radiation exposure.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.8K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
511
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
642